Sino Biological,Inc. (SHE:301047)

Market Cap	7.99B +8.7%
Revenue (ttm)	727.69M +18.0%
Net Income	157.25M +56.0%
EPS	1.29 +61.7%
Shares Out	121.64M
PE Ratio	50.82
Forward PE	n/a
Dividend	5.20 (8.16%)
Ex-Dividend Date	May 15, 2026

Volume	1,384,822
Open	63.80
Previous Close	63.70
Day's Range	63.77 - 66.62
52-Week Range	61.04 - 85.00
Beta	0.81
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Sino Biological,Inc.

Sino Biological,Inc. provides recombinant protein and antibody reagents for life science researchers in China and internationally. The company offers recombinant proteins, antibodies, cDNA clones, kits, serum-free media, protein modification, qPCR primers, cell lysates, and purification reagents. It also provides comprehensive solutions, including autoimmune disease research, kinase drug discovery, cytokine and growth factor, SARS-CoV-2 variants research, comprehensive CAR-T therapy, 3D organoids research, ADC development, influenza vaccine dev...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Employees: 1,069
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301047

Financial Performance

In 2025, Sino Biological,Inc.'s revenue was 699.56 million, an increase of 14.00% compared to the previous year's 613.67 million. Earnings were 147.74 million, an increase of 21.17%.